As of 30 Sep 2025, 40 institutional investors reported holding 24,623,944 shares of AC Immune SA - SHS (ACIU).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 10,000 | $31,300 | -$548,788 | $3.13 | 1 |
| 2025 Q3 | 24,623,944 | $71,148,777 | +$686,928 | $2.89 | 40 |
| 2025 Q2 | 24,501,946 | $49,722,343 | -$2,756,929 | $2.03 | 41 |
| 2025 Q1 | 25,917,900 | $48,452,492 | -$3,728,120 | $1.87 | 40 |
| 2024 Q4 | 27,368,510 | $73,887,369 | -$2,737,097 | $2.70 | 44 |
| 2024 Q3 | 28,199,176 | $106,590,963 | -$1,853,215 | $3.78 | 43 |
| 2024 Q2 | 28,573,335 | $114,006,597 | -$1,282,268 | $3.99 | 44 |
| 2024 Q1 | 28,964,304 | $85,733,267 | -$2,967,065 | $2.96 | 36 |
| 2023 Q4 | 29,638,667 | $148,194,005 | +$66,297,088 | $5.00 | 32 |
| 2023 Q3 | 15,981,631 | $45,548,797 | -$162,676 | $2.85 | 28 |
| 2023 Q2 | 16,033,728 | $47,380,324 | +$6,283,557 | $2.96 | 31 |
| 2023 Q1 | 14,097,734 | $32,988,033 | -$1,216,472 | $2.34 | 32 |
| 2022 Q4 | 14,762,259 | $30,113,226 | +$1,536,954 | $2.04 | 36 |
| 2022 Q3 | 14,018,294 | $44,297,207 | +$516,565 | $3.16 | 30 |
| 2022 Q2 | 13,801,401 | $49,820,603 | -$1,927,020 | $3.61 | 32 |
| 2022 Q1 | 14,291,722 | $57,166,356 | -$3,455,706 | $4.00 | 34 |
| 2021 Q4 | 15,047,623 | $74,486,031 | -$21,761,430 | $4.95 | 43 |
| 2021 Q3 | 17,659,276 | $118,497,474 | -$4,034,573 | $6.71 | 62 |
| 2021 Q2 | 18,193,441 | $144,277,000 | +$813,624 | $7.93 | 56 |
| 2021 Q1 | 18,204,501 | $138,526,610 | -$11,134,919 | $7.61 | 50 |
| 2020 Q4 | 19,803,074 | $102,381,000 | -$3,698,549 | $5.17 | 45 |
| 2020 Q3 | 20,709,959 | $101,062,895 | +$1,419,309 | $4.88 | 49 |
| 2020 Q2 | 20,384,455 | $137,182,286 | +$1,373,732 | $6.73 | 40 |
| 2020 Q1 | 20,169,972 | $139,370,146 | +$7,129,511 | $6.91 | 48 |
| 2019 Q4 | 19,092,604 | $162,661,000 | +$3,264,173 | $8.52 | 48 |
| 2019 Q3 | 18,791,229 | $93,011,000 | +$3,303,962 | $4.95 | 36 |
| 2019 Q2 | 18,070,499 | $100,291,000 | +$1,557,491 | $5.55 | 39 |
| 2019 Q1 | 17,932,668 | $90,557,000 | -$29,291,694 | $5.05 | 39 |
| 2018 Q4 | 20,248,444 | $191,350,000 | +$11,483,446 | $9.45 | 38 |
| 2018 Q3 | 19,139,638 | $153,117,000 | +$63,511,328 | $8.00 | 32 |
| 2018 Q2 | 10,991,993 | $102,314,000 | -$2,765,543 | $9.31 | 15 |
| 2018 Q1 | 11,284,927 | $116,687,000 | +$935,616 | $10.34 | 18 |
| 2017 Q4 | 11,172,927 | $143,012,000 | +$18,288,250 | $12.80 | 21 |
| 2017 Q3 | 9,744,158 | $109,858,000 | -$3,309,337 | $11.24 | 15 |
| 2017 Q2 | 10,277,545 | $90,441,000 | -$2,444,655 | $8.80 | 17 |
| 2017 Q1 | 10,506,484 | $108,837,000 | +$18,140,263 | $10.36 | 19 |
| 2016 Q4 | 8,747,097 | $112,668,000 | +$3,754,400 | $12.98 | 19 |
| 2016 Q3 | 8,240,474 | $135,720,000 | +$135,720,000 | $16.47 | 32 |